the cost of a recalcitrant intravenous drug user with serial cases of endocarditis: need for guidelines to improve the continuum of care
Clicks: 185
ID: 221934
2017
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
185 views
30 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #40 of 64 articles by views in optics letters
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
We report a case of an intravenous drug user (IVDU) patient who had 4 episodes of endocarditis within a 2-year time period in rural Georgia. The institutional cost was approximately $380,000. The lack of an established transitional care plan for IVDUs to outpatient care is a common phenomenon at institutions. Guidelines are essential to optimize the quality of care rendered to IVDUs with such infections, to assist providers in utilizing limited resources, and to limit the cost to the institutions.
| Reference Key |
libertin2017idcasesthe
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Claudia R. Libertin;Ulas M. Camsari;Walter C. Hellinger;Terry D. Schneekloth;Teresa A. Rummans |
| Journal | optics letters |
| Year | 2017 |
| DOI |
10.1016/j.idcr.2017.02.001
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.